January 21, 2018 6:26 AM ET

Healthcare Equipment and Supplies

Company Overview of Bioness Inc.

Company Overview

Bioness Inc. designs, develops, and distributes medical devices for people with stroke, multiple sclerosis, traumatic brain injury, cerebral palsy, and spinal cord injury. It offers L300, a foot drop system for people with various neurological conditions; L300 Plus for foot drop and thigh weakness, which delivers programmed, low-level electrical stimulation to activate the nerves controlling the muscles of the leg; H200, a wireless hand rehabilitation system for reaching, grasping, opening, and closing the hand; and StimRouter, an implantable neuromodulation device designed to treat intractable pain of peripheral nerve origin. The company also offers StimRouter, an implantable neuromodulatio...

25103 Rye Canyon Loop

Valencia, CA 91355

United States

Founded in 2004





Key Executives for Bioness Inc.

Chief Executive Officer and President
Chief Medical Officer
Compensation as of Fiscal Year 2017.

Bioness Inc. Key Developments

Bioness and Ottobock Announce Strategic European Distribution Partnership

Bioness Inc. and Ottobock together are partnering to expand distribution and access of functional electrical stimulation (FES) technologies in the European Union, UK, Switzerland, Norway, Turkey and India. The collaboration will combine technologies and resources to transform the mobility management paradigm, deliver medical solutions and expand product reach while improving the user experience. Ottobock will begin product commercialization within its Orthotics Division starting September 2017 and distribute Bioness' complete FES portfolio for the lower (L300 Go System) and upper extremities (H200 Wireless® System). Bioness and Ottobock share many mutual customers; this strategic partnership will enable both organizations to improve technology access as well as enhance the healthcare provider and patient experience.

Bioness to Introduce Products at the 2017 American Physical Therapy Association's Combined Sections Meeting

Bioness Inc. announced it will feature its full suite of innovative technologies at the American Physical Therapy Association's (APTA) Combined Sections Meeting (CSM) from February 16-18 in San Antonio, TX. Bioness clinical solutions are focused on helping clinicians improve outcomes in the value-based economy. Attendees will have the chance to experience Bioness implantable and external neuromodulation systems, robotic systems and software based therapy programs at booths #1319 and #1261. Innovative solutions debuting at APTA-CSM include: L300 Go™ System with augmented reality product experience; BITS Bedside; and Vector Gait and Safety System® with Intuitive Body Weight Support. The recently FDA cleared L300 Go™ System is the first functional electrical stimulation (FES) device to provide 3D motion detection of gait events using a 3-axis gyroscope and accelerometer technology. Patients facing mobility challenges due to neurological injury or disease, such as stroke, multiple sclerosis, traumatic brain injury or spinal cord injury, have less control over their lower extremity muscles which increases fall risk and reduces social participation. By monitoring patient movement in all three planes of motion and deploying stimulation to provide ankle dorsiflexion and knee flexion or extension precisely when needed during the gait cycle, Bioness is further improving therapist efficiency in detecting a gait event. The L300 Go now includes the myBioness mobile iOS application to keep home users engaged in the rehabilitation process and motivated to meet recovery goals. For the first time, CSM attendees will be able to experience an augmented reality demonstration of the new L300 Go and its advancements, and learn more about how the device can improve hemiparetic gait. BITS Bedside: Most rehabilitation activities are designed to be performed from a standing position, however, many rehab patients are confined to their beds for medical reasons. To help tackle this challenge, Bioness will be unveiling BITS Bedside, a new clinical solution that will allow clinicians to engage rehab patients that are unable to leave their bed or controlled rehabilitation space. Clinicians can challenge patients with physical and cognitive programs and assessments. The new technology also provides the ability to track and document progress, with the goal of keeping patients engaged during this important phase of care. Vector Gait and Safety System with Intuitive Body Weight Support: The Vector System with Intuitive Body Weight Support is Simply Smarter Intuitive Body Weight Support is a revolutionary innovation that allows patients to further the real-world experience in the clinic to properly prepare them for the community. Clinicians maintain unparalleled safety and product for their patients while permitting an unparalleled level of activity and interaction. The Vector Gait and Safety System is designed to improve patient mobility and functional independence while increasing patient and clinician safety. Parameters are based on patient ability or activity which helps gain confidence and allows clinicians to get more creative and aggressive during treatment. In addition, clinicians can run, record and document standardized tests to measure patient outcomes within the Vector software interface.

Bioness Inc. Receives FDA Clearance for the L300 Go™ System

Bioness Inc. announced that it received clearance from the U.S. Food and Drug Administration (FDA) for the L300 Go™ System. The L300 Go builds upon the global success of the company's NESS L300® Foot Drop System and NESS L300 Plus® System with numerous advancements, including the introduction of 3D motion detection of gait events, multi-channel stimulation and a mobile iOS application to track user activity. Gait movement disorders, such as foot drop and knee instability, are often associated with an upper motor neuron disease such as stroke and multiple sclerosis as well as injuries to the brain and spinal cord. Individuals with an impaired gait have less control over their lower extremity muscles and are at an increased risk for falls. The L300 Go is the first functional electrical stimulation (FES) system to offer 3D motion detection of gait events and muscle activation using data from a 3-axis gyroscope and accelerometer. Patient movement is monitored in all three kinematic planes and stimulation is deployed precisely when needed during the gait cycle. An adaptive, learning algorithm accommodates changes in gait dynamics, and a high speed processor that deploys stimulation within 10 milliseconds of detecting a valid gait event. This rapid, reliable response is critical and supports user confidence. The new myBioness™ mobile iOS application allows home users of the system to track activity, set personal goals and review their progress over time using dynamic reporting capabilities. The app has been designed to keep users engaged in the rehabilitation process and motivated to meet their recovery goals. Multi-channel stimulation is an additional noteworthy L300 Go feature that allows clinicians to precisely control the amount of dorsiflexion and inversion/eversion the system provides. Using a new, proprietary electrode, medial and lateral stimulation can be adjusted independently. This more efficient fitting process saves valuable time and facilitates more productive therapy sessions. Bioness will begin commercial release of the L300 Go in the spring of 2017. Initially, the system will only be available to healthcare professionals for clinic use. Home user availability is targeted for the later part of 2017. Current users of the L300 Foot Drop System and L300 Plus System will be eligible for a Customer Loyalty Upgrade Program which is designed to make the new technology more accessible for users in the clinic and community.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
NYC2012, Inc. United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Bioness Inc., please visit www.bioness.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.